Stock UniverseDerived research view · source repositories remain read-only

Centessa Pharmaceuticals plc (CNTA)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
39.19
Global Rank
517
Market Cap
3.92B
Latest Close
39.62
RS Composite
27.96% · G#323

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
0.05%
3M
52.68%
6M
36.29%
1Y
216.20%
3Y
778.49%
5Y
82.16%
10Y
82.16%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.70M · 30-day average: 1.26M · Max drawdown over stored range: -88.19%

Research Snapshot

Relative Strength vs SPX

RS Composite27.96%
20D RS-0.61%
60D RS31.42%
120D RS38.77%
Global RS Rank323 · 90.37% percentile
Qualified+ RS Rank133 · 89.43% percentile
Group ScopeQualified+
Primary RS Rank53 · 88.43% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank61 / 701
Primary Percentile91.44
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-0545.00Mn/a-256.69M-250.64M-1.78-345.74Mn/an/a141Mn/a-5.70%-5.57%-7.68%n/a276.59M110.44M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-1.78-22.3x$0.32124.0xn/an/a$-2.45-16.1x

Shares Diluted: 141M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0006.853015
Revenue Growth (YoY)
Gross Profit0006.8530
Operating Income-10.44-139.331-210.283-171.283-201.055
Free Cash Flow-10.63-136.344-201.683-160.511-142.089-194.188
Free Cash Flow Per Share-0.709-1.814-2.159-1.669-1.241-1.43085
EPS (Diluted) GAAP-0.710866-5.069694-2.314837-1.570896-2.05949
EPS Growth
EPS Non-GAAP
Gross Margin2700%2700%2700%100%2700%100%
Operating Margin2700%2700%2700%-2499.387%2700%-1384.61%
Profit Margin2700%2700%2700%-2204.655%2700%-1316.88%
Free Cash Flow Margin2700%2700%2700%-2342.2%2700%-1294.59%
Shares Outstanding (Diluted)1575.166593.400596.1776114.4734135.716
Shares Change (YoY)2700%401.11%24.258%2.973%19.023%18.557%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-0515.00Mn/a-79.77M-5.32%-79.24M-5.28%-0.52153.55M276.59M110.44Mprocessed
2025 Q42026-03-310.00n/a-68.47Mn/a-66.16Mn/a-0.47141.98M294.58M110.09Mprocessed
2025 Q32025-11-0515.00Mn/a-53.79M-3.59%-54.89M-3.66%-0.41134.16M246.21M109.82Mprocessed
2025 Q22025-08-1215.00Mn/a-54.65M-3.64%-50.34M-3.36%-0.38133.68M250.72M109.55Mprocessed
2025 Q12025-05-1415.00Mn/a-30.78M-2.05%-26.14M-1.74%-0.20133.03M284.50M109.25Mprocessed
2024 Q42025-03-24n/an/a-74.58Mn/a-111.33Mn/a-0.84132.18M482.18M108.94Mprocessed
2024 Q32024-11-12n/an/a-46.41Mn/a-42.57Mn/a-0.37116.25M518.45M75.70Mprocessed
2024 Q22024-08-13n/an/a-43.98Mn/a-43.82Mn/a-0.40109.49M294.83M76.50Mprocessed
2024 Q12024-05-13n/an/a-36.09Mn/a-38.05Mn/a-0.3899.89M230.18M76.80Mprocessed
2023 Q42024-03-28n/an/a-35.18Mn/a-36.84Mn/a-0.3897.94M256.55M75.70Mprocessed
2023 Q32023-11-13n/an/a-40.21Mn/a-38.65Mn/a-0.4096.65M281.34M74.00Mprocessed
2023 Q22023-08-14n/an/a-47.02Mn/a-24.89Mn/a-0.2695.16M303.59M73.30Mprocessed
2023 Q12023-05-12n/an/a-48.88Mn/a-50.71Mn/a-0.5394.94M346.23M71.60Mprocessed
2022 Q42023-03-30n/an/a-41.60Mn/a-43.17Mn/a-0.4694.62M393.64M69.80Mprocessed
2022 Q32022-11-10n/an/a-49.03Mn/a-53.88Mn/a-0.5794.33M444.84M68.20Mprocessed
2022 Q22022-08-10n/an/a-68.41Mn/a-64.66Mn/a-0.6994.11M484.16M67.40Mprocessed
2022 Q12022-05-16n/an/a-53.22Mn/a-54.50Mn/a-0.6090.51M544.47M74.80Mprocessed
2021 Q42022-03-30n/an/a-58.29Mn/a-60.77Mn/a-0.6691.87M595.08M75.70Mprocessed
2021 Q32021-11-15n/an/a-38.31Mn/a-40.16Mn/a-0.4589.90M578.82Mn/aprocessed
2021 Q22021-08-16n/an/a-41.29Mn/a-41.45Mn/a-0.6563.52M613.76Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.